[Comment] ILD risk prediction in routine care for rheumatoid arthritis

Rheumatoid arthritis-associated interstitial lung disease (ILD) is one of the most serious extra-articular manifestations of rheumatoid arthritis, being strongly associated with increased morbidity, mortality, and health-care costs. The possibility of ILD should be systematically considered both at initial evaluation and throughout longitudinal follow-up of patients with rheumatoid arthritis. Rheumatologists play a key role in screening for rheumatoid arthritis-associated-ILD, as early recognition and assessment are essential to ensure timely treatment and limit disease progression.